Source Scientific Systems
This article was originally published in The Gray Sheet
Executive Summary
Original equipment manufacturer of diagnostic equipment and instruments sold by parent MicroProbe Corp. to the Alton Group for $1.5 mil. in cash and a $950,000 noninterest-bearing, subordinated, secured note payable on March 27, 1995. Source Scientific, which is being renamed Alton Biomedical Corp., will continue to supply MicroProbe with instruments used in its Affirm DNA probe-based diagnostic system. MicroProbe had purchased Source Scientific Systems in July 1991 to "gain instrument system development and manufacturing capabilities" for the Affirm; currently, however, Source's "OEM business is not properly aligned with MicroProbe's strategic objectives and core, oligonucleotide- based technologies," the company said Jan. 25
You may also be interested in...
Incyte Hopes To Augment Immune/Inflammation Pipeline With Escient Deal
Incyte will pay $750m to acquire privately held Escient and its first-in-class oral antagonists of Mas-related G protein-coupled receptors X2 and X4.
Sanofi Clinches Key Phase III Immunology Win With Rilzabrutinib
Sanofi’s BTK inhibitor – one of two from its 2021 Principia buy – passed a Phase III test in immune thrombocytopenia as the company focuses on Dupixent-like blockbusters going forward.
US FDA Gene Therapy Accelerated Approval Guidance Will Describe ‘Buckets’ Of Use Scenarios
Forthcoming guidance is expected to describe areas of “low-hanging fruit” and those that are more challenging for use of the expedited pathway, Center for Biologics Evaluation and Research Director Peter Marks said.